Opportunity Overview
<p><span style="color: rgb(51, 51, 51);">The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.</span></p>
This is one of 897 active United States Other opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Food and Drug Administration |
|---|---|
| Country | United States |
| Category | Other |
| Estimated value | $900,000 |
| NAICS | 93.103 |
| Published | July 11, 2025 |
| Procurement stage | Request for Proposal (RFP) |
| Response due | May 16, 2028 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: U.S. Government (Simpler.Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.
Related Opportunities in United States
See every United States Other opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Other intelligence report in your inbox
A personalized report on United States Other opportunities, emailed in 5-10 minutes. One per month, no account needed.